فضلا اضغط بالاسفل
يستعمل دواء كيموكارب 10 مجم / مل 450 مجم فيالkemocarb 10mg/ml 450mg vial antineoplastic antineoplastic
description -an organoplatinum compound that possesses antineoplastic activity. - -indication -for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents - for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy including patients who have been previously treated with cisplatin. - -mechanism of action alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to dna bases resulting in the dna being fragmented by repair enzymes in their attempts to replace the alkylated bases preventing dna synthesis and rna transcription from the affected dna 2) dna damage via the formation of cross-links (bonds between atoms in the dna) which prevents dna from being separated for synthesis or transcription and 3) the induction of mispairing of the nucleotides leading to mutations. - -
تركيبة دواءكيموكارب 10 مجم / مل 450 مجم فيالkemocarb 10mg/ml 450mg vial
يتركب هذا الدواء من :carboplatin
الشركة المنتجة لدواءكيموكارب 10 مجم / مل 450 مجم فيالkemocarb 10mg/ml 450mg vial
هذا الدواء من انتاج شركة fresenius kabi > egyptian group for import and export
جرعة دواءكيموكارب 10 مجم / مل 450 مجم فيال
Welcome to Dlildwa, specifically the page of kemocarb 10mg/ml 450mg vial.
تم استعراض بدائل هذا الدواء 353 مرة